Musculoskeletal injuries and disorders are the leading cause of physical disability worldwide and a considerable socioeconomic burden. The lack of effective therapies has driven the development of novel bioengineering approaches that have recently started to gain clinical approvals. In this review, we first discuss the self-repair capacity of the musculoskeletal tissues and describe causes of musculoskeletal dysfunction. We then review the development of novel biomaterial, immunomodulatory, cellular, and gene therapies to treat musculoskeletal disorders. Last, we consider the recent regulatory changes and future areas of technological progress that can accelerate translation of these therapies to clinical practice. Description This Review discusses recent efforts in translating state-of-the-art bioengineering approaches to therapies for musculoskeletal regeneration.
Translating musculoskeletal bioengineering into tissue regeneration therapies
A. Khodabukus,T. Guyer,A. Moore,M. Stevens,R. Guldberg,N. Bursac
Published 2022 in Science Translational Medicine
ABSTRACT
PUBLICATION RECORD
- Publication year
2022
- Venue
Science Translational Medicine
- Publication date
2022-10-12
- Fields of study
Medicine, Engineering
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
CITED BY
Showing 1-27 of 27 citing papers · Page 1 of 1